Fimbriae

Records for this ingredient, by country (identity only).

ATC — · 4 markets · 11 records

Fimbriae 4 markets · 11 records Forms
Filters
MarketSG 3HK 2FR 2CA 1
Kind

SG 3 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

  • 0.003 mg/0.5 mLinjection CombinationDiphtheria Toxoid Adsorbed + Fimbriae 0.003 mg/0.5 mL + Pertactin Adsorbed 2 LF/0.5 mL + Pertussis 0.005 mg/0.5 mL + Pertussis 5 LF/0.5 mL + Tetanus Toxoid AdsorbedADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML
  • 0.005 mg per mL / per unit basis not statedinjection Combinationω-3鱼油脂肪乳 0.003 mg + Diphtheria Toxoid Adsorbed 5 LF + Filamentous Haemagglutinin Adsorbed 0.005 mg + Fimbriae 0.005 mg + Pertactin Adsorbed 0.0025 mg + Pertussis Toxoid Adsorbed 2 LF + Tetanus Toxoid AdsorbedAdacel®, Suspension for
  • 0.005 mg/0.5 mLinjection Combinationω-3鱼油脂肪乳 0.003 mg/0.5 mL + Diphtheria Toxoid Adsorbed + Filamentous Haemagglutinin Adsorbed 0.005 mg/0.5 mL + Fimbriae 0.005 mg/0.5 mL + Inactivated Poliomyelitis Vaccine + Inactivated Poliomyelitis Vaccine + Inactivated Poliomyelitis Vaccine 5 LF + Pertactin Adsorbed 0.0025 mg/0.5 mL + Pertussis Toxoid Adsorbed 2 LF + Tetanus Toxoid AdsorbedADACEL®-POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ADACEL POLIO VACCINE ×1ADACEL VACCINE ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

Combination products containing this ingredient

  • 0.005 mg/0.5 mLinjection CombinationDiphtheria Toxoid + Fimbriae 0.005 mg/0.5 mL + Pertactin 0.003 mg/0.5 mL + Tetanus ToxoidREPEVAX, suspension injectable en seringue préremplie. Vaccin diphtérique, tétanique, coquelucheux (acellulaire, multicomposé) et poliomyélitique (inactivé), (adsorbé, à teneur réduite en antigène(s))
  • 0.005 mg/0.5 mLinjection CombinationDiphtheria Toxoid + Fimbriae 0.005 mg/0.5 mL + Hepatitis B Surface Antigen 0.01 mg/0.5 mL + Pertactin 0.003 mg/0.5 mL + Tetanus ToxoidVAXELIS, suspension injectable en seringue préremplie. Vaccin diphtérique, tétanique, coquelucheux (acellulaire, multicomposé), de l'hépatite B (ADNr), poliomyélitique (inactivé) et conjugué de l'Haemophilus de type b (adsorbé)

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Combination products containing this ingredient

  • 0.005 mg per mL / per unit basis not statedliquid CombinationDiphtheria Toxoid 15 LF + Filamentous Haemagglutinin 0.005 mg + Fimbriae 0.005 mg + Pertactin 0.003 mg + Pertussis Toxoid 0.01 mg + Tetanus Toxoid 5 LFTripacel

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.